Young blood transfusion refers to transfusing blood specifically from a young person into an older one with the intention of creating a health benefit.[1] The efficacy and safety of young blood transfusions for anti-aging purposes remain a subject of debate in the scientific community, with limited clinical evidence in humans.[1][2][3] There are also concerns of harm.[3] While some preclinical studies on animals suggest potential benefits, there is a lack of robust clinical evidence to support its use in humans.[4][5][6][7][8][9] The U.S. Food and Drug Administration, in 2019, cautioned "consumers against receiving young donor plasma infusions" stating that they are an "unproven treatment".[3]
^ abcCite error: The named reference FDA2019 was invoked but never defined (see the help page).
^Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, Rando TA (February 2005). "Rejuvenation of aged progenitor cells by exposure to a young systemic environment". Nature. 433 (7027): 760–764. Bibcode:2005Natur.433..760C. doi:10.1038/nature03260. PMID15716955.
^Mccay CM, Pope F, Lunsford W, Sperling G, Sambhavaphol P (1957). "Parabiosis between old and young rats". Gerontologia. 1 (1): 7–17. doi:10.1159/000210677. PMID13405201.